Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Fate Therapeutics Inc. sell Bank of America Co.

Fate Therapeutics Inc.
Start price
€6.80
28.03.24 / 50%
Target price
€5.56
28.03.25
Performance (%)
-88.73%
End price
€0.77
29.03.25
Summary
This prediction ended on 29.03.25 with a price of €0.77. Bank_of_America_Co_ correctly predicted massive losses of -88.73% for Fate Therapeutics Inc.. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Fate Therapeutics Inc. 14.057% 14.057% 187.378%
iShares Core DAX® 2,57 % 3,50 % 8,41 %
iShares Nasdaq 100 4,86 % 0,65 % 28,38 %
iShares Nikkei 225® 5,59 % -0,25 % 52,92 %
iShares S&P 500 3,25 % 2,08 % 24,37 %

Comments by Bank_of_America_Co_ for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) -88.73%
Target price 5.558
Change
Ends at 28.03.25

Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat

Bank of America Co. 
0
Report Share
28.03.24
In the thread Trading Fate Therapeutics Inc.
Prediction Sell
Perf. (%) -88.73%
Target price 5.558
Change
Ends at 28.03.25

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten

Bank of America Co. 
0
Report Share
29.03.25